Combined in vitro effects of temozolomide and erucic acid on U87 MG cell viability, oxidative stress, and expression of genes involved in apoptotic signalling
References
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96. doi: 10.1056/NEJMoa043330
- Pu J, Yuan K, Tao J, Qin Y, Li Y, Fu J, Li Z, Zhou H, Tang Z, Li L, Gai X, Qin D. Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance. Discov Oncol 2025;16:731. doi: 10.1007/s12672-025-02567-3
- Altinoz MA, Bilir A, Elmaci İ. Erucic acid, a component of Lorenzo's oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis. Chem Biol Interact 2018;294:107–17. doi: 10.1016/j.cbi.2018.08.024
- Zhen Q, Xu Y, Xu Y, Liu X, Zhang Y, Ye D, Han S, Liu S, Zhang Y. Erucic acid, derived by Lactobacillus crispatus, induces ferroptosis in cervical cancer organoids through the PPAR-δ signaling pathway. Adv Sci (Weinh) 2025;12:e12599. doi: 10.1002/advs.202512599
- Nazıroğlu A, Çarhan A, Nazıroğlu M. Erucic acid increases the potency of cisplatin-induced colorectal cancer cell death and oxidative stress by upregulating the TRPM2 channel. Cell Biol Int 2024;48:1862–76. doi: 10.1002/cbin.12248
- Eh Suk VR, Chung I, Misran M. Mixed oleic acid-erucic acid liposomes as a carrier for Anticancer Drugs. Curr Drug Deliv 2020;17:292–302. doi: 10.2174/1567201817666200210122933
- Guo Z, Bergeron KF, Lingrand M, Mounier C. Unveiling the MUFA-cancer connection: insights from endogenous and exogenous perspectives. Int J Mol Sci 2023;24(12):9921. doi: 10.3390/ijms24129921
- Silva JA, Colquhoun A. Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells. Biomedicines 2023;11:779. doi: 10.3390/biomedicines11030779
- Zhang J, Stevens MF, Bradshaw TD. Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 2012;5:102–14. doi: 10.2174/1874467211205010102
- Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, Kaina B. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 2007;26:186–97. doi: 10.1038/sj.onc.1209785
- Sharma B, Gupta P, Biswas L, Verma AK, Pasha AM, Thota P, Medhi B. Neuroprotective potential of erucic acid via inhibition of N2a cell lines and rotenone induced Parkinson's disease rat model. Indian J Pharmacol 2023;55:376–84. doi: 10.4103/ijp.ijp_314_23.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4
- Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–9. doi: 10.1016/j.clinbiochem.2003.10.014
- Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–11. doi: 10.1016/j.clinbiochem.2005.08.008
- Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006;160:171–7. doi: 10.1016/j.toxlet.2005.07.001
- Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 2018;25:486–541. doi: 10.1038/s41418-017-0012-4
- Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of nonapoptotic cell death pathways. Nat Rev Mol Cell Biol 2014;15:135–47. doi: 10.1038/nrm3737
- Güner A, Nalbantsoy A, Sukatar A, Karabay Yavaşoğlu NÜ. Apoptosis-inducing activities of Halopteris scoparia L. Sauvageau (Brown algae) on cancer cells and its biosafety and antioxidant properties. Cytotechnology 2019;71:687–704. doi: 10.1007/s10616-019-00314-5
- Campos-Sandoval JA, Gómez-García MC, Santos-Jiménez JL, Matés JM, Alonso FJ, Márquez J. Antioxidant responses related to temozolomide resistance in glioblastoma. Neurochem Int 2021;149:105136. doi: 10.1016/j.neuint.2021.105136
- Nowacka A, Śniegocki M, Ziółkowska E. Oxidative stress and antioxidants in glioblastoma: mechanisms of action, therapeutic effects and future directions. Antioxidants 2025;14(9):1121. doi: 10.3390/antiox14091121
- Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 2013;332:237–48. doi: 10.1016/j.canlet.2012.01.007
- Sang DP, Li RJ, Lan Q. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27. Acta Pharmacol Sin 2014;35:832–8. doi: 10.1038/aps.2014.22
- Bak DH, Kang SH, Choi DR, Gil MN, Yu KS, Jeong JH, Lee NS, Lee JH, Jeong YG, Kim DK, Kim DK, Kim JJ, Han SY. Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy. Exp Ther Med 2016;11:2153–62. doi: 10.3892/etm.2016.3196
- Aksüt Y, Şengelen A, Gürsoy DM, Öğütcü İ, Kuvet Ö, Pekmez M. Chrysin sensitizes glioblastoma cells and spheroids to temozolomide treatment by reducing EMT and stemness phenotypes, as well as targeting multidrug resistance proteins. Front Pharmacol 2025;16:1643186. doi: 10.3389/fphar.2025.1643186
- Bharti V, Watkins R, Kumar A, Shattuck-Brandt RL, Mossing A, Mittra A, Shen C, Tsung A, Davies AE, Hanel W, Reneau JC, Chung C, Sizemore GM, Richmond A, Weiss VL, Vilgelm AE. BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. Cell Rep 2022;41:111826. doi: 10.1016/j.celrep.2022.111826
- Kaina B. Temozolomide, procarbazine and nitrosoureas in the therapy of malignant gliomas: update of mechanisms, drug resistance and therapeutic implications. J Clin Med 2023;12(23):7442. doi: 10.3390/jcm12237442
- Beltzig L, Schwarzenbach C, Leukel P, Frauenknecht KBM, Sommer C, Tancredi A, Hegi ME, Christmann M, Kaina B. Senescence is the main trait induced by temozolomide in glioblastoma cells. Cancers (Basel) 2022;14(9):2233. doi: 10.3390/cancers14092233
- Gorgakilas AG, Martin OA, Bonner WM. p21: a two-faced genome guardian. Trends Mol Med 2017;23:310–9. doi: 10.1016/j.molmed.2017.02.001
- Ferreira C, Sarmento B, Martins C. In vitro models of the interplay between glioblastoma and blood-brain barrier for stratifying drug efficacy. Adv Drug Deliv Rev 2025;227:115702. doi: 10.1016/j.addr.2025.115702
- Jurič A, Zandona A, Lovaković BT, Rašić D, Pizent A, Kozina G, Katalinić M, Vrdoljak AL, Karačonji IB. Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line. Arh Hig Rada Toksikol 2021;72:333–42. doi: 10.2478/aiht-2021-72-3604
- Topalović D, Živković L, Borozan S, Santibanez JF, Spremo-Potparević B. An in vitro evaluation of the cytotoxic potential of medicinal mushrooms against human breast cancer cell lines. Arh Hig Rada Toksikol 2024;75:297–302. doi: 10.2478/aiht-2024-75-3915
- Zandona A, Marcelić L, Žunec S, Madunić J, Katalinić M. Effects of N-alkyl quaternary quinuclidines on oxidative stress biomarkers in SH-SY5Y cells. Arh Hig Rada Toksikol 2025;76:203–10. doi: 10.2478/aiht-2025-76-4007
Language: English
Page range: 123 - 131
Submitted on: Jan 1, 2026
Accepted on: May 1, 2026
Published on: Jun 30, 2026
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Related subjects:
© 2026 İbrahim Gecili, Sıdıka Genç, Ahmet Hacımüftüoğlu, Adem Güner, Esmanur Niğde, Kübra Karabulut, Dündar Okan Yıllar, Ali Taghizadehehghalehjoughi, Abdelaty Mostafa Abdelaty Hassibelnaby, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution 4.0 License.